Obesity - A risk factor for microvascular and neuropathic complications in diabetes?

Diabetologia Croatica

Volumn 32, Issue 2, 2003, Pages 73-78

  Tomić, Martina ^a   Poljičanin, Tamara ^a   Pavlić Renar, Ivana ^a   Metelko, Željko ^a  

^a University of Zagreb   (Croatia)

Author keywords

Body mass index; Diabetic nephropathy; Diabetic neuropathy; Diabetic retinopathy; Other risk factors

Indexed keywords

ALBUMIN; CHOLESTEROL; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; ORAL ANTIDIABETIC AGENT; TRIACYLGLYCEROL;

ADULT; AGED; ALBUMIN BLOOD LEVEL; ARTICLE; BLOOD PRESSURE MEASUREMENT; BODY MASS; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORRELATION ANALYSIS; DIABETES CONTROL; DIABETIC MICROANGIOPATHY; DIABETIC NEUROPATHY; DIABETIC RETINOPATHY; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; DISEASE DURATION; FEMALE; HUMAN; INSULIN TREATMENT; MAJOR CLINICAL STUDY; MALE; METABOLIC REGULATION; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; OPHTHALMOSCOPY; PREVALENCE; PROTEINURIA; RISK ASSESSMENT; RISK FACTOR; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; VIBRATION SENSE;

EID: 0042426091     PISSN: 03510042     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Walters DP, Gatling W, Houston AC, Mullee MA, Julious SA, Hill RD. Mortality in diabetic subjects: an eleven-year follow-up of a community based population. Diabet Med 1994;11:968-973.
2. Morrish NJ, Stevens LK, Head J, Fuller JH, Jarrett RJ, Keen H. A prospective study of mortality among middle-aged diabetic patients (the London cohort of the WHO Multinational Study of Vascular Disease in Diabetics) II: Associated risk factors. Diabetologia 1990;33:542-548.
3. Harris MI, Klein R, Welborn TA, Knuiman MV. Onset of NIDDM occurs at least 4-7 years before clinical diagnosis. Diabetes Care 1992;15:815-819.
4. Turner R, Cull C, Holman R. United Kingdom Prospective Diabetes Study 17: A 9-year update of a randomised controlled trial on the effect of improved metabolic control of complications in non-insulin dependent diabetes mellitus. Ann Intern Med 1996;124:136-145.
5. Lehtinen JM, Uusitupa M, Siitonen O, Pyorala K. Prevalence of neuropathy in newly diagnosed NIDDM and nondiabetic control subjects. Diabetes 1989;38:1307-1313.
6. Jarrett RJ. Duration of non-insulin dependent diabetes and development of retinopathy: analysis of possible risk factors. Diabet Med 1986;3:261-263.
7. Klein R, Klein BE, Moss SE. Relation of glycemic control to diabetic microvascular complications in diabetes mellitus. Ann Intern Med 1996;124:90-96.
8. Adler AI, Stratton IM, Neil HA, Yudkin JS Matthews DR, Cull CA, Wright AD, Turner RC, Holman RR. Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study. BMJ 2000;321:412-419.
9. Kaplan NM. The deadly quartet: upper-body obesity, glucose intolerance, hypertriglyceridemia and hypertension. Arch Intern Med 1989;149:1514-1520.
10. Stern MP. Diabetes and cardiovascular disease. The "common soil" hypothesis. Diabetes 1995;44:369-374.
11. Katsilambros NL, Tsapogas PC, Arvanitis MP, Tritos NA, Alexiou ZP, Rigas KL. Risk factors for lower extremity arterial disease in non-insulin dependent diabetic persons. Diabet Med 1996;13:243-246.
12. Haupt E, Benecke A, Haupt A, Herrmann R, Vogel H, Walter C. The KID Study VI: Diabetic complications and associated diseases in younger type 2 diabetics still performing a profession. Prevalence and correlation with duration of diabetic state, BMI and C-peptide. Endocrinol Diabetes 1999;107:435-441.
13. Yajnik CS, Naik SS, Bhat DS, Joshi VM, Shelgikar KM, Alberti KG, Hockaday TD. The relationship between obesity, plasma immunoreactive insulin concentration and blood pressure in newly diagnosed Indian type 2 diabetic patients. Diabet Med 1993;10:146-151.
14. Ayata E, Yumuk V, Gursu U, Izmir S, Samanci T, Osar Z, Damci T, Ozyazar M, Gorpe U, Ilkova H. Obesity: a heavy burden on type 2 diabetes mellitus. 17th International Diabetes Federation Congress, Nov 5-10, 2000, Mexico City, Mexico.
15. Vučić M, Petrović S, Mesić R, Ročić B. An automated immunoturbidimetric assay for HbA1c determination. Diabetol Croat 1998;27:85-90.
16. Demacker PNM, Boerma GJM, Baadenhuijsen H et al. Evaluation of accuracy of 20 different test kits for the enzymic determination of cholesterol. Clin Chem 1983;29:1916-1922.
17. Kostner GM, Molinari E, Pichler P. Evaluation of a new HDL2/HDL3 quantitation method based on precipitation with polyethylene glycol. Clin Chem Acta 1983;148:139-147.
18. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol without the use of the preparative ultracentrifuge. Clin Chem 1972;18:499.
19. McGowan MW, Artiss JD, Strandbergh DR et al. A peroxidase-coupled method for the colorimetric determination of serum triglycerides. Clin Chem 1983;29:538-542.
20. Rowe DJF, Dawnay A, Watts GF. Microalbuminuria in diabetes mellitus: review and recommendations for the measurement of albumin in urine. Ann Clin Biochem 1990;27:297-312.
21. Sanchez-Thorin JC. The epidemiology of diabetes mellitus and diabetic retinopathy. Int Ophthalmol Clin 1998;38:11-18.
22. Javitt JC, Aiello LP, Chiang Y, Ferris FL 3rd, Canner JK, Greenfield S. Preventive eye care in people with diabetes is cost-saving to the federal government. Implications for health-care reform. Diabetes Care 1994;17:909-917.
23. Brancati FL, Cusumano AM. Epidemiology and prevention of diabetic nephropathy. Curr Opin Nephrol Hypertens 1995;4:223-229.
24. FitzSimmons SC, Agodoa L, Striker L, Conti F, Striker G. Kidney disease of diabetes mellitus: NIDDK initiatives for the comprehensive study of its natural history, pathogenesis and prevention. Am J Kidney Dis 1989;13:7-10.
25. Boulton AJ. Lowering the risk of neuropathy, foot ulcers and amputation. Diabet Med 1998;15:57-59.
26. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977-986.
27. Reichard P, Nilsson BY, Rosenqvist V. The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus. N Engl J Med 1993;329:304-309.
28. Ohkubo Y, Kishikawa H, Araki E, Miyata T, Isami S, Motoyoshi S, Kojima Y, Furuyoshi N, Shichiri M. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin dependent diabetes mellitus: a randomized prospective 6-year study. Diabetes Res Clin Pract 1995;28:103-117.
29. UK Prospective Diabetes Study Group 38. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes. BMJ 1998;317:703-713.
30. Mokdad AH, Serdula MK, Dietz WH, Bowman BA, Marks JS, Koplan JP. The spread of the obesity epidemic in the United States, 1991-1998. JAMA 1999;282:1519-1522.
31. World Health Organisation. Obesity: preventing and managing the global epidemic. Report of the WHO Consultation on Obesity. Geneva: June 1997.
32. Calle EE, Thun MJ, Petrelli JM, Rodriguez C, Heath CW Jr. Body mass index and mortality in a prospective cohort of US adults. N Engl J Med 1999;341:1097-1105.
33. Harris MI. Hypercholesterolemia in diabetes and glucose intolerance in the U.S. population. Diabetes Care 1991;14:366-374.
34. Salomaa VV, Tuomilehto J, Jauhiainen M et al. Hypertriglyceridemia in different degrees of glucose intolerance in a Finnish population-based study. Diabetes Care 1992;15:657-665.
35. Klein R, Klein BEK, Moss SE. Is obesity related to microvascular and macrovascular complications in diabetes - The Wisconsin Epidemiologic Study of Diabetic Retinopathy. Arch Intern Med 1997;157:650-656.
36. Penno G, Giampietro O, Nannipieri M, Rizzo L, Rapuano A, Miccoli R, Bertolotto A, Cecere M, Luccheti A, Navalesi R. Increased urinary albumin excretion aggregates with atherosclerotic risk factors in type 2 (non-insulin dependent) diabetes mellitus. Acta Diabetol 1992;29:250-257.
37. Straub RH, Thum M, Hollerbach C, Palitzsch KD, Scholmerich J. Impact of obesity on neuropathic late complications in NIDDM. Diabetes Care 1994;17:1290-1294.
38. Bergstrom B, Lilja B, Osterlin S, Sundkvist G. Autonomic neuropathy in non-insulin dependent (type 2) diabetes mellitus. Possible influence of obesity. J Intern Med 1990;227:57-63.